That's why I have HeartFlow’s stock at the top of my watchlist!

HeartFlow, with a market capitalization of $3 billion, has only been publicly traded since mid-last year but now seems to have established the infrastructure for massive scaling. It is a medical technology company that uses AI to create personalized 3D models of the heart from conventional CT scans, allowing for non-invasive analysis of blood flow disorders and plaque deposits, thus enabling more precise treatment decisions. Profitability in Focus: On January 13, the J.P. Morgan Healthcare Conference took place. HeartFlow demonstrated that the...